Chlorhexidine susceptibility and <i>Eagle effect</i> in planktonic cells and biofilm of nosocomial isolates
Nenhuma Miniatura disponível
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, v.42, n.6, p.787-792, 2023
Resumo
The aim of this study is to evaluate the chlorhexidine gluconate (CHG) susceptibility in both planktonic cells and biofilm of 32 Gram-negative (Gn) and 6 Gram-positive (Gp) isolates by minimal inhibitory concentration (2-256 mu g/mL for Gn and 2-32 mu g/mL for Gp), minimal bactericidal concentration (4-256 mu g/mL for Gn and 2-32 mu g/mL for Gp) in planktonic cells, and minimal biofilm elimination concentration (128 >= 16,384 mu g/mL in Gn and 32 >= 16,384 mu g/mL in Gp) in biofilm environment. Our study showed that Gn isolates have higher minimal concentrations than Gp and bacteria in biofilms are more tolerant than planktonic ones. No correlation between MBC or MBEC and biofilm formation was statistically confirmed. The Eagle effect, previously described for antimicrobials and antifungals, was evidenced in this work for CHG, an antiseptic. Besides that, the phenomenon was described in 23/38 isolates (60.5%), raising minimal concentration up to >= 16,384 mu g/mL. Our study showed that clinical isolates have a high ability to form biofilm allowing them to tolerate CHG concentrations as high as the ones used in clinical practice. Therefore, attention should be given to the occurrence of this phenomenon to avoid false susceptibility results.
Palavras-chave
Chlorhexidine, Biofilm, Minimal inhibitory concentration, Resistance, Eagle effect
Referências
- Hemati S, 2020, NEW MICROB NEW INFEC, V38, DOI 10.1016/j.nmni.2020.100794
- Morrissey I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086669
- Kheljan MN, 2022, CURR MICROBIOL, V79, DOI 10.1007/s00284-022-02858-w
- Naparstek L, 2014, J ANTIMICROB CHEMOTH, V69, P1027, DOI 10.1093/jac/dkt487
- Reis MAO, 2022, BRAZ J INFECT DIS, V26, DOI 10.1016/j.bjid.2021.101666
- Prasetyoputri A, 2019, TRENDS MICROBIOL, V27, P339, DOI 10.1016/j.tim.2018.10.007
- Sarwar S, 2023, AM J INFECT CONTROL, V51, P178, DOI 10.1016/j.ajic.2022.05.018
- Stallbaum LR, 2021, J MED MICROBIOL, V70, DOI 10.1099/jmm.0.001451
- Vijayakumar R, 2018, J INFECT PUBLIC HEAL, V11, P812, DOI 10.1016/j.jiph.2018.05.011